Assessment and Key Targets for Therapy in the Post-Myocardial Infarction Patient with Left Ventricular Dysfunction

American Journal of Cardiology

Volumn 102, Issue 5 SUPPL., 2008, Pages 5G-12G

  Flaherty, James D ^a   Udelson, James E ^b   Gheorghiade, Mihai ^a   Wu, Edwin ^a   Davidson, Charles J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NEUROHORMONE; STREPTOKINASE; THALLIUM 201; TISSUE PLASMINOGEN ACTIVATOR;

ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ASSESSMENT; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART PERFORMANCE; HUMAN; MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 50949097729     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.06.005     Document Type: Article

References (54)

1. Fuster V., and Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 90 (1994) 2126-2142
2. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., Hand M., Hochman J.S., Krumholz H.M., Kushner F.G., Lamas G.A., et al., American College of Cardiology, American Heart Association, Canadian Cardiovascular Society. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 44 (2004) 671-719
3. Anderson J.L., Adams C.D., Antman E.M., Bridges C.R., Califf R.M., Casey Jr. D.E., Chavey WE I.I., Fesmire F.M., Hochman J.S., Levin T.N., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction). Circulation 116 (2007) 803-877
4. Achenbach S. Computed tomography coronary angiography. J Am Coll Cardiol 48 (2006) 1919-1928
5. Stecker E.C., Vickers C., Waltz J., Socoteanu C., John B.T., Mariani R., McAnulty J.H., Gunson K., Jui J., and Chugh S.S. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol 47 (2006) 1161-1166
6. Myerburg R.J., Kessler K.M., and Castellanos A. Sudden cardiac death: structure, function, and time-dependence of risk. Circulation 85 suppl (1992) I2-I10
7. White H.D., Norris R.M., Brown M.A., Brandt P.W., Whitlock R.M., and Wild C.J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76 (1987) 44-51
8. GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 329 (1993) 1615-1622
9. Bolognese L., Neskovic A.N., Parodi G., Cerisano G., Buonamici P., Santoro G.M., and Antoniucci D. Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation 106 (2002) 2351-2357
10. Erne P., Schoenenberger A.W., Burckhardt D., Zuber M., Kiowski W., Buser P.T., Dubach P., Resink T.J., and Pfisterer M. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA 297 (2007) 1985-1991
11. Bonow R.O. Identification of viable myocardium. Circulation 94 (1996) 2674-2680
12. Allman K.C., Shaw L.J., Hachamovitch R., and Udelson J.E. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39 (2002) 1151-1158
13. Tsuyuki R.T., Shrive F.M., Galbraith D., Knudtston M.L., and Graham M.M. Revascularization in patients with heart failure. CMAJ 175 (2006) 361-373
14. Kim R.J., Fieno D.S., Parrish T.B., Harris K., Chen E.L., Simonetti O., Bundy J., Finn J.P., Klocke F.J., and Judd R.M. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992-2002
15. Simonetti O.P., Kim R.J., Fieno D.S., Hillenbrand H.B., Wu E., Bundy J.M., Finn J.P., and Judd R.M. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218 (2001) 215-223
16. Kim R.J., Wu E., Rafael A., Chen E.L., Parker M.A., Simonetti O., Klocke F.J., Bonow R.O., and Judd R.M. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343 (2000) 1445-1453
17. Choi K.M., Kim R.J., Gubernikoff G., Vargas J.D., Parker M., and Judd R.M. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 104 (2001) 1101-1107
18. Bello D., Shah D.J., Farah G.M., Di Luzio S., Parker M., Johnson M.R., Cotts W.G., Klocke F.J., Bonow R.O., Judd R.M., Gheorghiade M., and Kim R.J. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 108 (2003) 1945-1953
19. Ito H., Tomooka T., Sakai N., Yu H., Higashino Y., Fujii K., Masuyama T., Kitabatake A., and Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 85 (1992) 1699-1705
20. Ito H., Maruyama A., Iwakura K., Takiuchi S., Masuyama T., Hori M., Higashino Y., Fujii K., and Minamino T. Clinical implications of the 'no reflow' phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 93 (1996) 223-228
21. Wu K.C., Zerhouni E.A., Judd R.M., Lugo-Olivieri C.H., Barouch L.A., Schulman S.P., Blumenthal R.S., and Lima J.A. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97 (1998) 765-772
22. Maggioni A.P., Zuanetti G., Franzosi M.G., Rovelli F., Santoro E., Staszewsky L., Tavazzi L., and Tognoni G. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI-2 results. Circulation 87 (1993) 312-322
23. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., Heo M., and Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335 (1996) 1933-1940
24. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., Hafley G., and Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341 (1999) 1882-1890
25. Huikuri H.V., Makikallio T.H., Raatikainen M.J., Perkiomaki J., Castellanos A., and Myerburg R.J. Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation 108 (2003) 110-115
26. Hathaway W.R., Peterson E.D., Wagner G.S., Granger C.B., Zabel K.M., Pieper K.S., Clark K.A., Woodlief L.H., Califf R.M., and GUSTO-I Investigators. Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. JAMA 279 (1998) 387-391
27. Siltanen P., Pohjola-Sintonen S., Haapakoski J., Makijarvi M., and Pajari R. The mortality predictive power of discharge electrocardiogram after first acute myocardial infarction. Am Heart J 109 (1985) 1231-1237
28. Buxton A.E., Sweeney M.O., Wathen M.S., Josephson M.E., Otterness M.F., Hogan-Miller E., Stark A.J., Degroot P.J., and PainFREE Rx II Investigators. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators. J Am Coll Cardiol 46 (2005) 310-316
29. Cleland J.G., Daubert J.C., Erdmann E., Freemantle N., Gras D., Kappenberger L., Tavazzi L., and Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
30. Perkiomaki J.S., Huikuri H.V., Koistinen J.M., Makikallio T., Castellanos A., and Myerburg R.J. Heart rate variability and dispersion of QT interval in patients with vulnerability to ventricular tachycardia and ventricular fibrillation after previous myocardial infarction. J Am Coll Cardiol 30 (1997) 1331-1338
31. Glancy J.M., Garratt C.J., Woods K.L., and de Bono D.P. QT dispersion and mortality after myocardial infarction. Lancet 345 (1995) 945-948
32. Zabel M., Klingenheben T., Franz M.R., and Hohnloser S.H. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study. Circulation 97 (1998) 2543-2550
33. Statters D.J., Malik M., Ward D.E., and Camm A.J. QT dispersion: problems of methodology and clinical significance. J Cardiovasc Electrophysiol 5 (1994) 672-685
34. Hohnloser S.H., Klingenheben T., Li Y.G., Zabel M., Peetermans J., and Cohen R.J. T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers. J Cardiovasc Electrophysiol 9 (1998) 1258-1268
35. Bloomfield D.M., Bigger J.T., Steinman R.C., Namerow P.B., Parides M.K., Curtis A.B., Kaufman E.S., Davidenko J.M., Shinn T.S., and Fontaine J.M. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 456-463
36. Tapanainen J.M., Still A.M., Airaksinen K.E., and Huikuri H.V. Prognostic significance of risk stratifiers of mortality, including T wave alternans, after acute myocardial infarction: results of a prospective follow-up study. J Cardiovasc Electrophysiol 12 (2001) 645-652
37. Gomes J.A., Cain M.E., Buxton A.E., Josephson M.E., Lee K.L., and Hafley G.E. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation 104 (2001) 436-441
38. Bigger Jr. J.T., and Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med 337 (1997) 1569-1575
39. el-Sherif N., Denes P., Katz R., Capone R., Mitchell L.B., Carlson M., Reynolds-Haertle R., and Cardiac Arrhythmia Suppression Trial/Signal-Averaged Electrocardiogram (CAST/SAECG) Substudy Investigators. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period. J Am Coll Cardiol 25 (1995) 908-914
40. Schrier R.W., and Abraham W.T. Hormones and hemodynamics in heart failure. N Engl J Med 341 (1999) 577-585
41. Mann D.L., Kent R.L., Parsons B., and Cooper IV G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 85 (1992) 790-804
42. Goodfriend T.L., Elliott M.E., and Catt K.J. Angiotensin receptors and their antagonists. N Engl J Med 334 (1996) 1649-1654
43. Jessup M., and Brozena S. Heart failure. N Engl J Med 348 (2003) 2007-2018
44. Malmberg K., Norhammar A., Wedel H., and Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99 (1999) 2626-2632
45. Ward K.D., Sparrow D., Landsberg L., Young J.B., Vokonas P.S., and Weiss S.T. The relationship of epinephrine excretion to serum lipid levels: the Normative Aging Study. Metabolism 43 (1994) 509-513
46. Reaven G.M., Lithell H., and Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 334 (1996) 374-381
47. Prasad A., and Quyyumi A.A. Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome. Circulation 110 (2004) 1507-1512
48. Pekkanen J., Linn S., Heiss G., Suchindran C.M., Leon A., Rifkind B.M., and Tyroler H.A. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 322 (1990) 1700-1707
49. Rosengren A., Hagman M., Wedel H., and Wilhelmsen L. Serum cholesterol and long-term prognosis in middle-aged men with myocardial infarction and angina pectoris: a 16-year follow-up of the Primary Prevention Study in Göteborg, Sweden. Eur Heart J 18 (1997) 754-761
50. Richards A.M., Nicholls M.G., Troughton R.W., Lainchbury J.G., Elliott J., Frampton C., Espiner E.A., Crozier I.G., Yandle T.G., and Turner J. Antecedent hypertension and heart failure after myocardial infarction. J Am Coll Cardiol 39 (2002) 1182-1188
51. Abraham W.T., Greenberg B.H., and Yancy C.W. Pharmacologic therapies across the continuum of left ventricular function. Am J Cardiol suppl 102 (2008) 21G-28G
52. Kadish A.H., Reiffel J.A., Naccarelli G.V., and DiMarco J.P. Device therapies in the post-myocardial infarction patient with left ventricular dysfunction. Am J Cardiol suppl 102 (2008) 29G-37G
53. Flaherty J.D., Davidson C.J., and Faxon D.P. Percutaneous coronary intervention for myocardial infarction with left ventricular dysfunction. Am J Cardiol suppl 102 (2008) 38G-41G
54. McCarthy P.M. Surgical therapies for post-myocardial infarction patients. Am J Cardiol suppl 102 (2008) 42G-46G